ARTICLE | Company News
Hybridon, Pharmacia Biotech AB other research news
February 26, 1996 8:00 AM UTC
The companies synthesized GEM91, an oligonucleotide with potential treatment for HIV, using Pharmacia's OligoProcess. The OligoProcess is a synthesis system that replicates molecules for use in genetic research and pilot scale drug formulation. ...